NEW YORK (TheStreet) -- Global alcoholic beverage giant Constellation Brands (STZ), known for products like Corona, Robert Mondavi wines and Svedka Vodka will report first-quarter fiscal 2016 earnings results Wednesday before the opening bell.
For the quarter that ended in May, Constellation Brands is projected to earn $1.23 a share on revenue of $1.6 billion, translating to increases of 15% and 6%, respectively. For the full year ending in February, earnings are projected to grow 10% to $4.88 a share, while revenue of $6.37 billion calls for growth of almost 6%.
That both quarter and full-year earnings are projected to grow at or almost twice the rate of revenue underscores the focus management has placed on its profit margins and retuning value to shareholders. And this would explain why shares of the Victor, New York-based company are already up some 20% in 2015, against 1% gains for the S&P 500 index.
So, while taking profits ahead of Wednesday's results would ordinarily seem like a smart move, in this case, it would be huge mistake.
This is a "cash machine that continues to execute well," said TheStreet's Jim Cramer in April. "Investors who sell the stock near current levels are going to wish they hadn't done so," he added.
Cramer was right. When he made those comments two months ago, the stock was up less than 1% on the year. But as he then also noted, Constellation Brands was already ahead of its peers in terms of revenue, suggesting the stock wouldn't stay depressed for long. And that's exactly the same position the company is in today.